Cell Machines, Inc. cellmachines.net


Public lists: BIO 2016 (619)

We have developed a scalable, multipurpose system for production of human therapeutic proteins that provides us with a tremendous cost advantage. Our first product is factor IX for the treatment of hemophilia B. This is currently an underserved $1.4 billion market. Only about 25% of the worlds patients are adequately treated due to limitations of cost and supply. Our product can be produced and sold for about 20% of the cost of current recombinant factor IX. For comparison, the entire yearl...Show all

We have developed a scalable, multipurpose system for production of human therapeutic proteins that provides us with a tremendous cost advantage. Our first product is factor IX for the treatment of hemophilia B. This is currently an underserved $1....Show all

Company (Alive / Active)

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cell Machines, Inc. $0M Nov 20, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cell Machines, Inc. Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods and compositions related to large scale production of proteins May 06, 2014 Application